Pharmacokinetic interactions between antiepileptic and antidepressant drugs

World Journal of Biological Psychiatry

Volumn 4, Issue 1, 2003, Pages 21-24

  Mula, Marco ^a   Trimble, Michael R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

antidepressant drugs; antiepileptic drugs; drug interactions; epilepsy; pharmacokinetic

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT;

CLASSIFICATION; DRUG INTERACTION; EATING DISORDER; HUMAN; MOOD DISORDER; PSYCHOSIS; REVIEW;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; DRUG INTERACTIONS; EATING DISORDERS; HUMANS; MOOD DISORDERS; PSYCHOTIC DISORDERS;

EID: 0037494711     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622970309167906     Document Type: Article

References (26)

1. Andersen BB, Mikkelsen M, Vesterager A, Dam M, Kristensen HB, Pedersen B, Lund J, Mengel H (1991) No influence of the antidepressant paroxetine on carbamazepine, valproate and phenytoin. Epilepsy Res 10:201-204.
2. Bonate PL, Kroboth PD, Smith RB, Suarez E, Oo C (2000) Clonazepam and sertraline: absence of drug interaction in a multiple-dose study. J Clin Psychopharmacol 20:19-27.
3. Fehr C, Crunder G, Hiemke C, Dahmen N (2000) Increase in serum clomipramine concentrations caused by valproate. J Clin Psychopharmacol 20:493-494.
4. Cidal BE, Anderson CD, Seaton TL, Miyoshi HR, Wilenksy AJ (1993) Evaluation of the effect of fluoxetine on the formation of carbamazepine epoxide. Ther Drug Monit 15:405-409.
5. Crimsley SR, Jann MW, Carter JG, D'Maello AP, D'Souza MJ (1991) Increased carbamazepine plasma concentrations after fluoxetine coadministration. Clin Pharmacol Ther 50:10-15.
6. Haselberger MB, Freedman LS, Tolbert S (1997) Elevated serum phenytoin concentrations associated with coadministration of sertraline. J Clin Psychopharmacol 17:107-109.
7. Kaufman KR, Gerner R (1998) Lamotrigine toxicity secondary to sertraline. Seizure 7:163-165.
8. Ketter TA, Post RM, Parekh PI, Worthington K (1995) Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatmentresistant depression. J Clin Psychiatry 56:471-475.
9. Laroudie C, Salazar DE, Cosson JP, Cheuvart B, Istin B, Girault J, Ingrand I, Decourt JP (2000) Carbamazepine-nefazodone interaction in healthy subjects. J Clin Psychopharmacol 20:46-53.
10. Leinonen E, Lepola U, Koponen H (1996) Substituting carbamazepine with oxcarbazepine increases citalopram levels. A report on two cases. Pharmacopsychiatry 29:156-158.
11. Nawishy S, Hathaway N, Turner P (1981) Interactions of anticonvulsant drugs with mianserin and nomifensine. Lancet 2:871-872.
12. Nelson DR, Koymans L, Kamataki T, Stegemn JJ, Feyereisen R, Waxman D], Waterman MR, Cotoh O, Coon MJ, Estabroon RW
13. Gunsalus IC, Nebert DW (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1-42.
14. Nelson MH, Birnbaum AK, Remmel RP (2001) Inhibition of phenyotin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors. Epilepsy Res 44:71-82.
15. Nemeroff CB, De Vane CL, Pollock BG (1996) Newer antidepressants and cytochrome P450 system. Am J Psychiatry 153:311-320.
16. Odishaw J, Chen C (2000) Effects of steady state bupropion on the pharmacokinetics of lamotrigine in healthy subjects. Pharamcotherapy 20:1448-1453.
17. Perucca E, Manzo L, Crema A (1985) Pharmacokinetic interactions between antiepileptic and psychotropic drugs. In: Trimble MR (ed) The psychopharmacology of epilepsy. John Wiley & Sons, London, pp 95-105.
18. Popli AP, Tanquary J, Lamparella V, Masand PS (1995) Bupropion and anticonvulsant drug interactions. Ann Clin Psychiatry 7:99-101.
19. Rapeport WG, Muirhead DC, Williams SA, Cross M, Wesnes K (1996a) Absence of effect of sertraline on the pharmacokinetics and pharmacodynamics of phenytoin. J Clin Psychiatry 57(Supp 1):24-28.
20. Rapeport WG, Williams SA, Muirhead DC, Dewland PM, Tanner T, Wesnes K (1996b) Absence of sertraline-mediated effect on the pharmacokinetics and pharmacodynamics of carbamazepine. J Clin Psychiatry 57(Suppl 1):20-23.
21. Sitsen J, Maris F, Timmer C (2001) Drug-drug interaction studies with mirtazapine and carbamazepine in healthy male subjects. Eur J Drug Metab Phamacokinet 26:109-121.
22. Spina E, Avenoso A, Pollicino AM, Caputi AP, Fazio A, Pisani F (1993) Carbamazepine coadministration with fluoxetine or fluvoxamine. Ther Drug Monit 15:247-250.
23. Szymura-Oleksiak J, Wyska E, Wasieczko A (2001) Pharmacokinetic interaction between imipramine and carbamazepine in patients with major depression. Psychopharmacology (Berl) 154:38-42.
24. Tekle A, al-Kamis Kl (1990) Phenytoin-bupropion interaction: effect on plasma phenytoin concentration in the rat. J Pharm Pharmacol 42:799-801.
25. Wong SL, Cavanaugh J, Shi H, Awni WM, Granneman GR (1996) Effects of divalproex sodium on amitriptyline and nortriptyline pharmacokinetics. Clin Pharmacol Ther 60:48-53.
26. Van Belle K, Sarre S, Ebinger G, Michotte Y (1995) Brain, liver and blood distribution kinetics of carbamazepine and its metabolic interaction with clomipramine in rats: a quantitative microdialysis study. J Pharmacol Exp Ther 272:1217-1222.